Murhandarwati E Elsa Herdiana, Wang Lina, Black Casilda G, Nhan Doan Hanh, Richie Thomas L, Coppel Ross L
Department of Microbiology, Monash University, Clayton, Victoria 3800, Australia.
Infect Immun. 2009 Oct;77(10):4510-7. doi: 10.1128/IAI.00360-09. Epub 2009 Jul 20.
Inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein 1 (MSP1(19)) are a significant component of inhibitory responses in individuals immune to malaria. Nevertheless, conflicting results have been obtained in determining whether this antibody specificity correlates with protection in residents of areas where malaria is endemic. In this study, we examined sera collected from a population of semi-immune individuals living in an area of Vietnam with meso-endemicity during a 6-month period. We used two Plasmodium falciparum parasite lines that express either endogenous MSP1(19) or the homologous region from Plasmodium yoelii to measure the MSP1(19)-specific inhibitory activity. We showed that (i) the level of MSP1(19)-specific inhibitory antibodies was not associated with a delay in P. falciparum infection, (ii) MSP1(19)-specific inhibitory antibodies declined significantly during the convalescent period after infection, and (iii) there was no significant correlation between the MSP1(19)-specific inhibitory antibodies and the total antibodies measured by enzyme-linked immunosorbent assay. These results have implications for understanding naturally acquired immunity to malaria and for the development and evaluation of MSP1(19)-based vaccines.
针对裂殖子表面蛋白1(MSP1(19))19-kDa片段的抑制性抗体是疟疾免疫个体抑制性反应的重要组成部分。然而,在确定这种抗体特异性是否与疟疾流行地区居民的保护作用相关方面,已得出相互矛盾的结果。在本研究中,我们检测了在6个月期间从越南中流行区半免疫个体群体中收集的血清。我们使用两种表达内源性MSP1(19)或约氏疟原虫同源区域的恶性疟原虫寄生虫株来测量MSP1(19)特异性抑制活性。我们发现:(i)MSP1(19)特异性抑制抗体水平与恶性疟原虫感染延迟无关;(ii)感染后的恢复期内,MSP1(19)特异性抑制抗体显著下降;(iii)MSP1(19)特异性抑制抗体与通过酶联免疫吸附测定法测量的总抗体之间无显著相关性。这些结果对于理解疟疾自然获得性免疫以及基于MSP1(19)的疫苗的开发和评估具有重要意义。